Viewing nowGripide Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
iCure Co., Ltd.

MFDS item code 201600980 · Approved 2016.02.22 · Insurance code 674400620
Improves blood glucose control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy, and when blood sugar control is insufficient, it may be combined with oral hypoglycemic agents or insulin. Especially in cases where control is difficult with sulfonylureas or metformin monotherapy, it is co-administered with metformin to enhance blood sugar control. Thus, this medication is effective in improving blood sugar control in patients with type 2 diabetes.
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended that the method described under Initial Dose be followed. That is, start at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medicine. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Additionally, it should not be administered to individuals allergic to this medication or sulfonylureas, patients with severe liver or kidney dysfunction, and women who are pregnant or breastfeeding. Patients with severe infections, pre- and post-operative periods, or those with severe trauma are also recommended to use insulin therapy instead. Individuals with gastrointestinal disorders that impair food absorption should be cautious as they may have a risk of hypoglycemia. In the first week of taking this medication, there is a high risk of hypoglycemia, so blood sugar levels should be closely monitored. Particularly, elderly patients, those with poor nutritional status or irregular meal patterns, individuals who have insufficient carbohydrate intake after excessive exercise, and those who consume large amounts of alcohol are more susceptible to hypoglycemia. Individuals with poor kidney or liver function and those taking other medications should also be cautious. Symptoms of hypoglycemia may appear with this medication, including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. Hypoglycemia usually recovers quickly after sugar intake, so it is advisable to always carry sugary foods. Additionally, gastrointestinal symptoms such as blurred vision, nausea, abdominal pain, diarrhea, abnormal liver function, blood abnormalities, and allergic reactions may occur, so any unusual symptoms should be promptly discussed with medical personnel. It is important to carry out dietary and exercise therapy in conjunction with this medication for blood sugar control, and continuous use is needed to see effects. As hypoglycemia may occur, it is essential to fully understand the symptoms and risk factors and to be cautious while driving or operating machinery. In stressful situations, infections, or surgeries that make blood sugar control difficult, switching to insulin therapy may be considered. It is safest for women who are pregnant or breastfeeding not to use this medication, and if planning to become pregnant, they should consult their doctor. In case of overdose, severe hypoglycemia may occur, so immediate emergency treatment and a visit to a medical facility should be obtained if symptoms arise. Lastly, the safety and efficacy of this medication in children have not been established, and dosages for the elderly should be adjusted based on renal function. This medication should be kept out of the reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. Storing this way will help to maintain the efficacy of the medication for a longer period.
Green rectangular tablets
30 tablets, 100 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
iCure Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.